These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 21940178

  • 1. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG.
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [Abstract] [Full Text] [Related]

  • 2. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 3. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H, Wierzbowska A, Robak T.
    Eur Cytokine Netw; 2003 Jan; 14(1):40-51. PubMed ID: 12799213
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma.
    Pappa CA, Tsirakis G, Devetzoglou M, Zafeiri M, Vyzoukaki R, Androvitsanea A, Xekalou A, Sfiridaki K, Alexandrakis MG.
    Tumour Biol; 2014 Jun; 35(6):5647-51. PubMed ID: 24563338
    [Abstract] [Full Text] [Related]

  • 5. Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma.
    Alexandrakis MG, Pappa CA, Miyakis S, Sfiridaki A, Kafousi M, Alegakis A, Stathopoulos EN.
    Eur J Intern Med; 2006 Oct; 17(6):412-6. PubMed ID: 16962948
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
    Tsirakis G, Pappa CA, Kanellou P, Stratinaki MA, Xekalou A, Psarakis FE, Sakellaris G, Alegakis A, Stathopoulos EN, Alexandrakis MG.
    Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG, Sfiridaki A, Miyakis S, Pappa C, Kandidaki E, Alegakis A, Margioris AN.
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [Abstract] [Full Text] [Related]

  • 12. Levels of the chemokines growth-related oncogene alpha and epithelial neutrophil-activating protein 78 are raised in patients with severe acute pancreatitis.
    Shokuhi S, Bhatia M, Christmas S, Sutton R, Neoptolemos JP, Slavin J.
    Br J Surg; 2002 May; 89(5):566-72. PubMed ID: 11972545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.
    Andersen NF, Standal T, Nielsen JL, Heickendorff L, Borset M, Sørensen FB, Abildgaard N.
    Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow microvascular density and angiogenic growth factors in multiple myeloma.
    Alexandrakis MG, Passam FJ, Ganotakis E, Dafnis E, Dambaki C, Konsolas J, Kyriakou DS, Stathopoulos E.
    Clin Chem Lab Med; 2004 Jan; 42(10):1122-6. PubMed ID: 15552270
    [Abstract] [Full Text] [Related]

  • 16. Differential induction of GRO alpha gene expression in human corneal epithelial cells and keratocytes exposed to proinflammatory cytokines.
    Cubitt CL, Lausch RN, Oakes JE.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1149-58. PubMed ID: 9152234
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG, Tonchev AB, Kolova P, Ivanova L, Gercheva L.
    Scand J Clin Lab Invest; 2008 May; 68(6):492-500. PubMed ID: 18609087
    [Abstract] [Full Text] [Related]

  • 18. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 19. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG.
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.